COVID-19–related mortality in patients with CLL over time. The COVID-19–related mortality in patients with CLL during different waves of COVID-19 (initial studies on the left) is depicted. Initial studies (up to 35%, on the left) reported the highest mortality rate for COVID-19, whereas more recent retrospective series documented a much lower mortality rate (1%-23%, depending on the setting of data collection).